Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome-Reference-Cited by-同舟云学术

Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome

Published:2016-06-14 Issue:1 Volume:31 Page:170-176
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Barrio S,Shanafelt T D,Ojha J,Chaffee K G,Secreto C,Kortüm K M,Pathangey S,Van-Dyke D L,Slager S L,Fonseca R,Kay N E,Braggio E

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/leu2016172.pdf

Reference34 articles.

1. Call TG, Phyliky RL, Noel P, Habermann TM, Beard CM, O'Fallon WM et al. Incidence of chronic lymphocytic leukemia in Olmsted County, Minnesota, 1935 through 1989, with emphasis on changes in initial stage at diagnosis. Mayo Clin Proc 1994; 69: 323–328.

2. Diehl LF, Karnell LH, Menck HR . The American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Data Base report on age, gender, treatment, and outcomes of patients with chronic lymphocytic leukemia. Cancer 1999; 86: 2684–2692.

3. Baliakas P, Hadzidimitriou A, Sutton LA, Rossi D, Minga E, Villamor N et al. Recurrent mutations refine prognosis in chronic lymphocytic leukemia. Leukemia 2015; 29: 329–336.

4. Stilgenbauer S, Schnaiter A, Paschka P, Zenz T, Rossi M, Dohner K et al. Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial. Blood 2014; 123: 3247–3254.

5. Rossi D, Bruscaggin A, Spina V, Rasi S, Khiabanian H, Messina M et al. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood 2011; 118: 6904–6908.

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell genomics-based immune and disease monitoring in blood malignancies;Clinical Hematology International;2024-06-14

2. Mouse models of chronic lymphocytic leukemia and Richter transformation: what we have learnt and what we are missing;Frontiers in Immunology;2024-06-06

3. Mouse models of CLL: In vivo modeling of disease initiation, progression, and transformation;Seminars in Hematology;2024-06

4. Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis;Blood Advances;2024-04-27

5. CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression;Frontiers in Oncology;2024-03-28